No abstract available
MeSH terms
-
Antiparkinson Agents / adverse effects*
-
Humans
-
Incidence
-
Japan / epidemiology
-
Methylprednisolone / administration & dosage
-
Methylprednisolone / pharmacology*
-
Methylprednisolone / therapeutic use*
-
Neuroleptic Malignant Syndrome / epidemiology*
-
Neuroleptic Malignant Syndrome / etiology*
-
Neuroprotective Agents / administration & dosage
-
Neuroprotective Agents / pharmacology*
-
Neuroprotective Agents / therapeutic use*
-
Parkinson Disease / drug therapy*
Substances
-
Antiparkinson Agents
-
Neuroprotective Agents
-
Methylprednisolone